![]() |
Afinitor (Everolimus) Combo For Breast Cancer Approved By FDA
The FDA has approved Afinitor (everolimus) in combination with Aromasin (exemestane) for the treatment of some postmenopausal females with advanced hormone-receptor positive, HER2-negative breast cancer...
More... |
| All times are GMT -7. The time now is 10:03 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021